Mitchell DY - Search Results

1

Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers.

Becker A, Martin EC, Mitchell DY, Grenningloh R, Bender AT, Laurent J, Mackenzie H, Johne A. Becker A, et al. Among authors: mitchell dy. Clin Transl Sci. 2020 Mar;13(2):325-336. doi: 10.1111/cts.12713. Epub 2019 Nov 29. Clin Transl Sci. 2020. PMID: 31654487 Free PMC article. Clinical Trial.

2

Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants.

Scheible H, Dyroff M, Seithel-Keuth A, Harrison-Moench E, Mammasse N, Port A, Bachmann A, Dong J, van Lier JJ, Tracewell W, Mitchell D. Scheible H, et al. Clin Transl Sci. 2021 Nov;14(6):2420-2430. doi: 10.1111/cts.13108. Epub 2021 Aug 10. Clin Transl Sci. 2021. PMID: 34374206 Free PMC article.

3

Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants.

Papasouliotis O, Mitchell D, Girard P, Dyroff M. Papasouliotis O, et al. Clin Transl Sci. 2022 Dec;15(12):2899-2908. doi: 10.1111/cts.13417. Epub 2022 Oct 17. Clin Transl Sci. 2022. PMID: 36165192 Free PMC article.

4

Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study.

Papasouliotis O, Mitchell D, Girard P, Dangond F, Dyroff M. Papasouliotis O, et al. Clin Transl Sci. 2022 Dec;15(12):2888-2898. doi: 10.1111/cts.13407. Epub 2022 Sep 30. Clin Transl Sci. 2022. PMID: 36126241 Free PMC article. Clinical Trial.

5

Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer.

Grevel J, Jentsch G, Austin R, Prins NH, Lettieri J, Mitchell D, Huang F, Brose MS, Schlumberger M, Meinhardt G, Peña CEA, Ploeger BA. Grevel J, et al. Clin Transl Sci. 2019 Sep;12(5):459-469. doi: 10.1111/cts.12634. Epub 2019 Apr 12. Clin Transl Sci. 2019. PMID: 30920122 Free PMC article. Clinical Trial.

6

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma.

Lin SM, Lu SN, Chen PT, Jeng LB, Chen SC, Hu CT, Yang SS, Le Berre MA, Liu X, Mitchell DY, Prins K, Grevel J, Peña CA, Meinhardt G. Lin SM, et al. Among authors: mitchell dy. Hepatol Int. 2017 Mar;11(2):199-208. doi: 10.1007/s12072-016-9774-x. Epub 2016 Dec 1. Hepatol Int. 2017. PMID: 27909950 Free PMC article. Clinical Trial.

7

The Patient-Centered Future of Clinical Pharmacology.

Shahin MH, Abdel-Rahman S, Hartman D, Johnson JA, Mitchell DY, Reynolds KS, Wagner JA, Morrissey KM. Shahin MH, et al. Among authors: mitchell dy. Clin Pharmacol Ther. 2020 Jan;107(1):72-75. doi: 10.1002/cpt.1681. Epub 2019 Nov 21. Clin Pharmacol Ther. 2020. PMID: 31751490 No abstract available.

8

Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.

Robinson RP, Reiter LA, Barth WE, Campeta AM, Cooper K, Cronin BJ, Destito R, Donahue KM, Falkner FC, Fiese EF, Johnson DL, Kuperman AV, Liston TE, Malloy D, Martin JJ, Mitchell DY, Rusek FW, Shamblin SL, Wright CF. Robinson RP, et al. Among authors: mitchell dy. J Med Chem. 2018 Apr 12;61(7):3237. doi: 10.1021/acs.jmedchem.8b00306. Epub 2018 Mar 28. J Med Chem. 2018. PMID: 29589934 No abstract available.

9

Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002.

Morlock RJ, Tan M, Mitchell DY. Morlock RJ, et al. Among authors: mitchell dy. Clin Ther. 2006 Jul;28(7):1044-53. doi: 10.1016/j.clinthera.2006.07.008. Clin Ther. 2006. PMID: 16990083

10

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies.

Lorusso PM, Adjei AA, Varterasian M, Gadgeel S, Reid J, Mitchell DY, Hanson L, DeLuca P, Bruzek L, Piens J, Asbury P, Van Becelaere K, Herrera R, Sebolt-Leopold J, Meyer MB. Lorusso PM, et al. Among authors: mitchell dy. J Clin Oncol. 2005 Aug 10;23(23):5281-93. doi: 10.1200/JCO.2005.14.415. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009947 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page